An artificial intelligence-based patient navigator tool demonstrated improved potential in helping to overcome patient attrition that can lead to colon cancer disparities, nearly doubling the rate of completed colonoscopies for people who did not show for their initial appointment. The research will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 31-June 4 in Chicago, Illinois.
“In a time when our health care system and workforce have not fully recovered from the ravages of the pandemic and cancer disparities continue to loom large, it is critical to identify effective and efficient ways to optimize patient care without placing additional burden on the system or staff. Our quality improvement project demonstrates the potential that artificial intelligence-based virtual navigation can have in meeting these criteria while promoting engagement in cancer screening in underserved populations who experience a disproportionate cancer burden in morbidity and mortality,” said lead study author Alyson Moadel, PhD, Deputy Director of Community Engagement & Cancer Health Equity, Founding Director, BOLD Psychosocial Oncology Program at the Montefiore Einstein Comprehensive Cancer Center”.
